Event ContactsPaid membership required to see this information
Small molecule drug discovery has approached a critical junction where the rigorous pre-clinical validation and prioritizing of novel targets is of utmost importance. Challenged with thinning development pipelines and significant losses in revenue, greater emphasis is being placed on the stringent selection and validation of targets and candidate molecules to increase success and reduce attrition rates in phase II trials. In response to this challenge, a synergy between drug discovery and chemical biology is emerging as a vital component to providing adequate confidence before launching full discovery programs. The development and utilization of high-quality chemical probes in combination with disease-relevant phenotypic systems provides a powerful approach to obtain a deeper interrogation of target-phenotype relationships - ultimately enriching target validation.
Cambridge Healthtech Institute is proud to announce the Inaugural Chemical Biology for Target Validation conference, established to convene an interdisciplinary collection of leaders in chemical/structural biology, chemical proteomics, medicinal chemistry, synthetic chemistry and chemogenomics to discuss strategies to de-risk novel discovery initiatives.
Contact the event managers listed below for more information about how you can participate at the Chemical Biology for Target Validation.
|Conference/Event Dates:||05/22/2014 - 05/23/2014|
|Other Industries:||Pharmaceutical, Professional Healthcare|
|Venue:||Westin Boston Waterfront|
|Venue Phone:||(617) 532-4600|
|Venue Type:||Indoor - Hotel|
|Official Conference Hotel:||Westin Boston Waterfront|
|Conference Hotel URL:||http://www.westinbostonwaterfront.com/...|
|Exhibit Floorplan:||Click Here|
|Booth Size||Booth Cost||Available Amenities|
|Call for information.||Electricity:||n/a|
|Marketing Vehicles Allowed:||Call|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.
- Analiza Inc.
- AnalytiCon Discovery
- AntiCancer Inc.
- Axiogenesis AG
- Biomodels, LLC
- Chemical Computing Group
- Collaborative Drug Discovery
- Domainex Ltd.
- Druggability Technologies Holdings Ltd
- EMD Millipore
- GVK Biosciences
- Halocarbon Products Corporation
- HEL Inc.
- Helium Software
- Horizon Discovery, Ltd.
- Intelligent Pharma
- IntelliSyn RD
- inviCRO, LLC
- InvitroCue Pte Ltd.
- IZON Science Ltd.
- The Jackson Laboratory
- JSR Life Sciences Corporation / SCIVAX Life Sciences, Inc.
- Mauna Kea Technologies
- Molecular Imaging, Inc.
- Molecular Response
- Oncotest GmbH
- OnTarget Chemistry
- OpenEye Scientific Software Inc.
- Optibrium Limited
- PharmAgra Labs, Inc.
- Reaction Biology Corporation
- Rilas Technologies, Inc.
- SAGE Labs
- Simulations Plus Inc.
- SOLVIAS AG
- Sophion Bioscience A/S
- Strem Chemicals, Inc.
- Sygnature Discovery Ltd.
- Thermo Fisher Scientific Maybridge and Acros Organics
- Vitas-M Laboratory
- Wilmington PharmaTech